Washington [US], June 7 (ANI): According to the findings of research led by the College of Engineering, Carnegie Mellon University, cell-based therapies have long been thought of as an alternative treatment option for patients with a range of diseases caused by organ and tissue failure, inclusive of heart attack, diabetes, corneal blindness, and cystic fibrosis. While great in theory, in practice, these therapies show limited clinical success in many applications due to low cell viability after injection, as well as poor retention at the injection site and engraftment into damaged tissue.
Wearable sensors that track everything from step count to heart rate are becoming increasingly common. Medical-grade gadgets, on the other hand, are useful to measure the beginning of frailty in older persons. Thereby, diagnose lethal diseases quickly, evaluate the efficacy of new medications, and follow the performance of professional sports. Engineers at the University of […]
\
\
\
\
